2024

• Le, H., Fajardo Lubian, A., Bowring, B., Van Der Poorten, D., Iredell, J., George, J., Venturini, C., Ahlenstiel, G., Read, S. (2024). Using a human colonoid-derived monolayer to study bacteriophage translocation. Gut Microbes, 16(1), 2331520. [More Information]

2023

• Fajardo Lubian, A., Venturini, C. (2023). Use of Bacteriophages to Target Intracellular Pathogens. Clinical Infectious Diseases, 77, S423-S432. [More Information]

2022

• Bell, J., Fajardo Lubian, A., Partridge, S., Gottlieb, T., Iredell, J., Daley, D., Coombs, G. (2022). Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GnSOP) Annual Report 2020. Communicable Diseases Intelligence, 46. [More Information]
• Bell, J., Fajardo Lubian, A., Partridge, S., Gottlieb, T., Robson, J., Iredell, J., Daley, D., Coombs, G. (2022). Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP). Communicable Diseases Intelligence, 46. [More Information]
• Venturini, C., Petrovic Fabijan, A., Fajardo Lubian, A., Barbirz, S., Iredell, J. (2022). Biological foundations of successful bacteriophage therapy. EMBO Molecular Medicine, 14(7), 1-20. [More Information]
• Venturini, C., Bowring, B., Partridge, S., Ben Zakour, N., Fajardo Lubian, A., Ayala Lopez, A., Qin, J., Totsika, M., Van Galen, G., Norris, J., Iredell, J. (2022). Co-Occurrence of Multidrug Resistant Klebsiella pneumoniae Pathogenic Clones of Human Relevance in an Equine Pneumonia Case. Microbiology Spectrum, 10(3). [More Information]

2021

• Venturini, C., Bowring, B., Fajardo Lubian, A., Devine, C., Iredell, J. (2021). Effects of antibiotic treatment with piperacillin/tazobactam versus ceftriaxone on the composition of the murine gut microbiota. Antimicrobial Agents and Chemotherapy, 65(2), 1-10. [More Information]

2020

• Bell, J., Fajardo Lubian, A., Partridge, S., Gottlieb, T., Iredell, J., Daley, D., Coombs, G. (2020). Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2019. Communicable Diseases Intelligence, 44. [More Information]
• Khalid, A., Fajardo Lubian, A., Ma, L., Lin, R., Iredell, J. (2020). Characterizing the role of porin mutations in susceptibility of beta lactamase producing Klebsiella pneumoniae isolates to ceftaroline and ceftaroline-avibactam. International Journal of Infectious Diseases, 93, 252-257. [More Information]

2019

• Fajardo Lubian, A., Ben Zakour, N., Agyekum, A., Qi, Q., Iredell, J. (2019). Host adaptation and convergent evolution increases antibiotic resistance without loss of virulence in a major human pathogen. PLoS Pathogens, 15(3), e1007218. [More Information]

2016

• Agyekum, A., Fajardo Lubian, A., Ansong, D., Partridge, S., Agbenyega, T., Iredell, J. (2016). blaCTX-M-15 carried by IncF-type plasmids is the dominant ESBL gene in Escherichia coli and Klebsiella pneumoniae at a hospital in Ghana. Diagnostic Microbiology and Infectious Disease, 84(4), 328-333. [More Information]
• Agyekum, A., Fajardo Lubian, A., Ai, X., Ginn, A., Zong, Z., Guo, X., Turnidge, J., Partridge, S., Iredell, J. (2016). Predictability of Phenotype in Relation to Common beta-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae. Journal of Clinical Microbiology, 54(5), 1243-1250. [More Information]

2014

• Fajardo Lubian, A., Hernando-Amado, S., Oliver, A., Ball, G., Filloux, A., Martinez, J. (2014). Characterization of a novel Zn2+-dependent intrinsic imipenemase from Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy, 69(11), 2972-2978. [More Information]